-
Mashup Score: 3Outcomes with Immune Checkpoint Inhibitors in Patients with MTAP Alterations in Advanced Urothelial Carcinoma - Rafee Talukder - 6 month(s) ago
Rafee Talukder discusses his presentation on his research into the effects of MTAP loss on survival rates among advanced urothelial cancer patients undergoing immunotherapy. With the help of an extensive international database, his team found that patients with this MTAP loss exhibited worse observed response rates and a trend toward poorer progression-free survival. In addition, the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4The Treatment Landscape of Metastatic Urothelial Carcinoma: First-Line Systemic Therapy in Cisplatin Eligible Patients - 6 month(s) ago
Metastatic Urothelial Carcinoma, bladder cancer, cisplatin, cisplatin eligibility for bladder cancer treatment, Avelumab Maintenance Therapy, JAVELIN Bladder 100 trial, Treatment Landscape of Metastatic Urothelial Carcinoma.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
The treatment landscape of metastatic #UrothelialCarcinoma: 1st-line systemic therapy in cisplatin eligible pts. @RKSayyid & @zklaassen_md assess criteria for determining cisplatin chemotherapy eligibility and review landmark trials and clinical data > https://t.co/eyEMtYmhaK https://t.co/CercY53LLE
-
-
Mashup Score: 2
Ashish Kamat welcomes Charles Guo to discuss variant histology in bladder urothelial carcinoma, which constitutes about 90% of all bladder cancers. Dr. Guo meticulously explains the WHO classification into noninvasive and invasive types, detailing distinguishing features, aggressive behaviors, and distinct genomic alterations of various subtypes like micropapillary, plasmacytoid, and small cell…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Outcomes with Immune Checkpoint Inhibitors in Patients with MTAP Alterations in Advanced Urothelial Carcinoma - Rafee Talukder - 7 month(s) ago
Rafee Talukder discusses his presentation on his research into the effects of MTAP loss on survival rates among advanced urothelial cancer patients undergoing immunotherapy. With the help of an extensive international database, his team found that patients with this MTAP loss exhibited worse observed response rates and a trend toward poorer progression-free survival. In addition, the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Outcomes with Immune Checkpoint Inhibitors in Patients with MTAP Alterations in Advanced Urothelial Carcinoma - Rafee Talukder - 7 month(s) ago
Rafee Talukder discusses his presentation on his research into the effects of MTAP loss on survival rates among advanced urothelial cancer patients undergoing immunotherapy. With the help of an extensive international database, his team found that patients with this MTAP loss exhibited worse observed response rates and a trend toward poorer progression-free survival. In addition, the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Management of Low-Grade Upper Tract Urothelial Carcinoma: Case-Based Presentation - Rashid Sayyid - 7 month(s) ago
Zachary Klaassen is joined by Rashid Sayyid to present a case-based discussion on the management of low-grade upper tract urothelial carcinoma. They focus on a 68-year-old female patient, detailing her medical history, symptoms, and diagnostic workup, including CT urogram, according to the American Urological Association (AUA) guidelines. They explore various considerations such as standardized…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Guidelines and Real-World Scenarios in Upper Tract Urothelial Carcinoma Treatment - Kyle Rose - 7 month(s) ago
In a case presentation, Zach Klaassen and Kyle Rose discuss the complexities of treating low-grade upper tract urothelial carcinoma. Dr. Rose presents a case of a 69-year-old male patient with the condition, emphasizing the importance of thorough workup and staging. The discussion covers the challenges of accurate biopsy sampling and the potential for under-staging or over-staging patients. Dr….
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma - 7 month(s) ago
Our partner journal Future Oncology has recently published a Clinical Trial Protocol manuscript, which details the Phase II JAVELIN Bladder Medley umbrella trial.
Source: www.oncology-central.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Choosing JELMYTO®: A Patient's Journey Through Less Invasive Upper Tract Urothelial Carcinoma Treatment - Tom Murphy - 7 month(s) ago
In the wake of being diagnosed with upper tract urothelial cancer (UTUC), patient Tom Murphy navigates through his treatment options, ultimately settling on JELMYTO® (mitomycin) treatment. This less invasive procedure consists of six weekly treatments which were, according to Murphy, relatively simple and unobtrusive to his everyday life. Expressing gratitude for the guidance and support of his…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with Second-Line Immune Checkpoint Inhibitors - Beyond the Abstract - 7 month(s) ago
Bellmunt Risk Score, Eastern Cooperative Oncology Group (ECOG) performance status (PS), hemoglobin levels and presence of liver metastases, advanced urothelial cancer (aUC) progressing after platinum-based chemotherapy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
Outcomes with immune checkpoint inhibitors in patients with MTAP alterations in advanced #UrothelialCarcinoma. @rafee_talukder @fredhutch joins @PGrivasMDPhD @UW to discuss the effects of MTAP loss on survival rates on UroToday > https://t.co/h0RckbxsCz https://t.co/Xdd81hHEWN